Literature DB >> 28892933

Evaluation of the Relationship between Serum 25-Hydroxy Vitamin D and Hypertension in Hamadan, Iran-A Case Control Study.

Behshad Naghshtabrizi1, Shiva Borzouei2, Pedram Bigvand3, Mohamad Ali Seifrabiei4.   

Abstract

INTRODUCTION: Hypertension or high blood pressure is one of the main reasons of fatality in the world. The role of vitamin D in developing hypertension has not been proved yet. Some studies have shown positive correlation between low serum vitamin D level and hypertension. Due to this fact, recognising hypertension risk factors such as potential impact of low serum vitamin D level seems to be required. AIM: This study was conducted to evaluate potential impact of serum vitamin D level on hypertension.
MATERIALS AND METHODS: This case-control study had 188 subjects including 55 cases suffering from hypertension and 133 controls with normal blood pressure in Hamadan, Iran. After taking the medical history and physical examination, 5 cc of their blood was taken to measure their serum 25-Hydroxyvitamin D [25(OH)D] level through ELISA test. Data analysis was done by version 16.0 of SPSS software and used independent sample t-test and Chi-square test for related comparisons.
RESULTS: Mean and standard deviation of serum 25(OH)D level in patients suffering from hypertension was 13.10±9.7 ng/ml and in control group was 20.87±10.34 ng/ml. This variance was statistically significant (p<0.001). Mean serum 25(OH)D level in both case and control groups was measured after gender and age stratification. Mean serum 25(OH)D level in cases and controls was 13.12±11.4 ng/ml and 21.38±11.47 ng/ml in males (p=0.016) and 13.10±9.91 ng/ml and 19.19±10.55 ng/ml (p=0.004) in females, respectively. Mean serum 25(OH)D level in under 50-year-old was 10.82±8.73 ng/ml and 20.07±11.17 ng/ml in cases and controls respectively (p<0.001). In over 50-year-old, there was no significant relationship between mean serum 25(OH)D and blood pressure levels (p>0.05).
CONCLUSION: According to this study, reverse relationship between serum 25(OH)D and blood pressure levels was seen.

Entities:  

Keywords:  High blood pressure; Risk factor; Vitamin deficiency

Year:  2017        PMID: 28892933      PMCID: PMC5583848          DOI: 10.7860/JCDR/2017/25522.10187

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

1.  1,25-dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study.

Authors:  Suzanne E Judd; Sara N Raiser; Meena Kumari; Vin Tangpricha
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-24       Impact factor: 4.292

Review 2.  Vitamin D, blood pressure, and African Americans: toward a unifying hypothesis.

Authors:  Stephen G Rostand
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 8.237

3.  Racial disparity in blood pressure: is vitamin D a factor?

Authors:  Kevin Fiscella; Paul Winters; Dan Tancredi; Peter Franks
Journal:  J Gen Intern Med       Date:  2011-04-21       Impact factor: 5.128

Review 4.  Vitamin D in atherosclerosis, vascular disease, and endothelial function.

Authors:  LaPrincess C Brewer; Erin D Michos; Jared P Reis
Journal:  Curr Drug Targets       Date:  2011-01       Impact factor: 3.465

5.  Association between vitamin D levels and blood pressure in a group of Puerto Ricans.

Authors:  Yajaira Caro; Verónica Negrón; Cristina Palacios
Journal:  P R Health Sci J       Date:  2012-09       Impact factor: 0.705

6.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Authors:  Yan Chun Li; Juan Kong; Minjie Wei; Zhou-Feng Chen; Shu Q Liu; Li-Ping Cao
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 7.  Epidemiology and heterogeneity of hypertension in Iran: a systematic review.

Authors:  Ali-Akbar Haghdoost; Behnam Sadeghirad; Mohammad Rezazadehkermani
Journal:  Arch Iran Med       Date:  2008-07       Impact factor: 1.354

Review 8.  Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.

Authors:  Yan Chun Li; Guilin Qiao; Milan Uskokovic; Wei Xiang; Wei Zheng; Juan Kong
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

9.  The relationship between vitamin D levels and nondipper hypertension.

Authors:  Samet Yilmaz; Fatih Sen; Ozcan Ozeke; Ahmet Temizhan; Serkan Topaloglu; Dursun Aras; Sinan Aydogdu
Journal:  Blood Press Monit       Date:  2015-12       Impact factor: 1.444

10.  Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women.

Authors:  M B Snijder; P Lips; J C Seidell; M Visser; D J H Deeg; J M Dekker; R M van Dam
Journal:  J Intern Med       Date:  2007-06       Impact factor: 8.989

View more
  2 in total

Review 1.  Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.

Authors:  William B Grant; Henry Lahore; Sharon L McDonnell; Carole A Baggerly; Christine B French; Jennifer L Aliano; Harjit P Bhattoa
Journal:  Nutrients       Date:  2020-04-02       Impact factor: 5.717

Review 2.  Is the shielding effect of cholecalciferol in SARS CoV-2 infection dependable? An evidence based unraveling.

Authors:  Shaik Lahoor Basha; Sake Suresh; V V Ashok Reddy; S P Surya Teja
Journal:  Clin Epidemiol Glob Health       Date:  2020-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.